JP Morgan Healthcare Conference, Day 4: Cepheid, Fluidigm | GenomeWeb

By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up on Thursday with a handful of life science tools and molecular diagnostics companies presenting to investors, including Sequenom, which spoke about its goal to bill 25,000 MaterniT21 tests in 2012.

Below are capsules of presentations from two other companies that presented on the fourth day of the conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.